Rocket Pharmaceuticals, Inc. Common Stock (RCKT) is a publicly traded Healthcare sector company. As of May 21, 2026, RCKT trades at $2.98 with a market cap of $335.22M and a P/E ratio of -1.47. RCKT moved +1.37% today. Year to date, RCKT is -16.34%; over the trailing twelve months it is -56.64%. Its 52-week range spans $2.19 to $18.89. Analyst consensus is buy with an average price target of $9.67. Rallies surfaces RCKT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rocket Pharmaceuticals, Inc. Common Stock (RCKT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. RCKT moved +1.37% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $2.98 |
| Market Cap | $335.22M |
| P/E Ratio | -1.47 |
| EPS | $-2.01 |
| Dividend Yield | 0.00% |
| 52-Week High | $18.89 |
| 52-Week Low | $2.19 |
| Volume | 540 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-223.12M |
| Gross Margin | 0.00% |
13 analysts cover RCKT: 0 strong buy, 7 buy, 4 hold, 2 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.67.